Burstable Health Team
Health In-Focus
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
2243 articles
Articles
Nutritional Products International Announces New Initiatives to Streamline U.S. Market Entry for International Brands
With its turnkey Evolution of Distribution system, Nutritional Products International provides international health, wellness, beauty, and sports nutrition brands a fully managed entry into the world’s largest retail market — all under one roof.
November 18, 2025Read more
MediKeeper Forecasts Critical 2026 Workplace Wellness Trends: Mental Health Crisis, AI Integration, and Combating Health Misinformation
MediKeeper, a leading provider of wellness portals, has released its annual forecast of emerging trends in the employee wellness market for 2026, identifying critical challenges and opportunities facing organizations. The trends, based on data from over 1,700 client organizations and 10 million covered lives, point to a wor...
November 18, 2025Read more
AI-Powered Medical Coding Partnership Enhances Healthcare Revenue Cycle for Massachusetts Community Health Center
XpertDox has formed a strategic partnership with Community Health Programs, Inc., a Federally Qualified Health Center serving Berkshire County, Massachusetts, to implement artificial intelligence technology for medical coding and revenue cycle management. The collaboration focuses on improving coding quality scores, support...
November 18, 2025Read more
New Book 'Scared to Move On' Offers Medically-Informed Path to Emotional Healing After Betrayal
Dr. Leonnardo Andre has released a new book titled Scared to Move On that addresses the emotional challenges people face when trying to love again after experiencing betrayal and broken trust. The book explores the vulnerable space between fear and hope through the intertwined journeys of protagonists Francine and Leonardo,...
November 18, 2025Read more
GRE Alpha Announces Exclusive North American Distribution for JDI's LumiFree LED Technology
GRE Alpha Electronics, Ltd. has announced an exclusive distributorship agreement with Japan Display Inc. to bring LumiFree LED lighting fixtures to North America. This strategic partnership positions GRE Alpha at the forefront of next-generation lighting technology that virtually eliminates light distribution waste while de...
November 18, 2025Read more
Former Space Shuttle Engineer Publishes Book on Energy Therapy for Anxiety Management
Mark L. Fox, former Space Shuttle Chief Engineer and inventor of the VIBE pocket-sized Pulsed Electromagnetic Field device, has released a new book presenting energy therapy as a science-based approach to managing anxiety without pharmaceutical intervention. The book, titled "Go Find Joy: The Science of Calm: Erasing Anxiet...
November 17, 2025Read more
Annovis Bio's Buntanetap Shows Promise in Halting Cognitive Decline in Parkinson's Patients with Alzheimer's Co-pathology
Annovis Bio Inc. released new findings from its Phase 3 early Parkinson's disease study demonstrating that buntanetap halted cognitive decline across all patients and delivered the strongest benefit in those with mild dementia and amyloid co-pathology. This subgroup represents approximately 25% of the study population and t...
November 17, 2025Read more
CNS Pharmaceuticals Reports Progress on Brain Cancer Drug TPI 287 in Third-Quarter Results
CNS Pharmaceuticals Inc. has reported third-quarter 2025 financial results while highlighting significant progress with its lead drug candidate TPI 287, a blood-brain barrier-permeable abeotaxane being developed for glioblastoma and other central nervous system tumors. The company's Phase 1 clinical data demonstrated potent...
November 17, 2025Read more
NRx Pharmaceuticals Reports Q3 2025 Progress in Suicidal Depression Treatments
NRx Pharmaceuticals, Inc. reported third-quarter 2025 results while highlighting substantial progress across its clinical pipeline, particularly for treatments targeting suicidal depression. The company noted its first revenue-generating activities alongside key regulatory advancements for both NRX-100 and NRX-101 programs....
November 17, 2025Read more
NanoViricides Reports Progress on Broad-Spectrum Antiviral NV-387 Amid Public Health Concerns
NanoViricides, Inc. has filed its Form 10-Q for the quarter ended September 30, 2025, detailing substantial progress on its lead drug candidate NV-387, a first-in-class broad-spectrum antiviral designed to resist viral escape by mimicking conserved sulfated proteoglycan receptors used by more than 90% of viruses. The compan...
November 17, 2025Read more
Keep A Breast Foundation Marks 25-Year Partnership Milestone with Vans Warped Tour
The Keep A Breast Foundation concluded its 25th anniversary celebrations during the final weekend of Vans Warped Tour in Orlando, marking a significant milestone for both organizations. KAB first joined the tour in 1998, creating a partnership that has spanned decades and transformed how breast health education reaches youn...
November 17, 2025Read more
Nursing Student Awarded Scholarship for Analysis of Healthcare Workforce Crisis
Schenk Nursing Home Abuse Law announced Justin Coffman as the recipient of the 2025 Fighting the Nursing Shortage Scholarship, a $2,000 award supporting nursing students at accredited U.S. institutions. The scholarship program encourages applicants to explore how the healthcare industry can become more accessible to incomin...
November 17, 2025Read more
Ergonomic Furniture Reaches Historic Low Prices During 2025 Black Friday Season
The 2025 Black Friday season has triggered a fundamental shift in the ergonomic furniture market, with premium office chairs and standing desks reaching their lowest price points ever recorded. Odinlake's month-long Mega Sale, running from November 1 to December 1, 2025, represents what industry analysts describe as a pivot...
November 16, 2025Read more
Molly & Me Pecans Launches Whiskey Salted Caramel Pecans, Blending Indulgence with Nutrition
Molly & Me Pecans has unveiled its newest flavor offering, Whiskey Salted Caramel Pecans, creating a snack option that balances indulgent taste with nutritional value. The product combines the natural richness of pecans with whiskey-infused caramel and sea salt, creating what the company describes as a harmonious blend of s...
November 15, 2025Read more
Peptide Research Advances Understanding of Metabolic Regulation, Tissue Repair, and Antioxidant Mechanisms
Peptide research continues to advance our understanding of metabolic regulation, tissue repair, and antioxidant mechanisms, with several compounds showing particular promise in experimental settings. Tirzepatide operates as a dual receptor agonist, engaging both glucose-dependent insulinotropic polypeptide and glucagon-like...
November 14, 2025Read more
Research Peptide Quality Standards Essential for Experimental Reproducibility
Research peptides serve as critical molecular instruments for examining signaling pathways, receptor interactions, and various biological mechanisms in both in vitro and in vivo environments. These specific sequences of amino acids function as ligands, substrates, or modulators, enabling researchers to detect particular bio...
November 14, 2025Read more
CNS Pharmaceuticals Advances Brain Cancer Treatment Targeting Blood-Brain Barrier Challenge
CNS Pharmaceuticals Inc. is intensifying its focus on glioblastoma multiforme, an aggressive brain cancer with limited treatment options that represents one of oncology's most significant unmet needs. CEO John Climaco emphasized the company's commitment to overcoming the blood-brain barrier, a major obstacle in brain cancer...
November 14, 2025Read more
HeartBeam Advances Toward FDA Clearance for Breakthrough 3D Cardiac Monitoring Technology
HeartBeam Inc. reported third-quarter 2025 financial results while highlighting significant progress toward commercialization of its 12-lead ECG synthesis software, now in the final stage of FDA 510(k) review with anticipated clearance expected by year end. The company's technology represents a potential breakthrough in car...
November 14, 2025Read more
GLP-1 Medications Show 50% Lower Mortality in Colon Cancer Patients, UC San Diego Study Finds
Colon cancer patients using GLP-1 medications such as Ozempic and Wegovy demonstrated a 50% lower mortality rate compared to those not taking these drugs, according to recent research from UC San Diego. The findings suggest that medications already approved for specific clinical indications may have additional therapeutic b...
November 14, 2025Read more
Peptides Emerge as Versatile Biochemical Modulators with Broad Therapeutic Implications
Peptides, consisting of short chains of amino acids linked by peptide bonds, serve as essential biochemical modulators with significant implications for therapeutic research and experimental design. These molecules function as either signaling or structural entities, with their sequence, structure, and chemical characterist...
November 14, 2025Read more
Precision in Peptide Preparation: Essential Practices for Research Integrity and Reproducibility
Accurate peptide preparation and reconstitution techniques are fundamental to maintaining research integrity and experimental reproducibility across scientific disciplines. The precise calculation of peptide concentrations forms the foundation of reliable research workflows, where concentration is determined by dividing pep...
November 14, 2025Read more